This reference contains the names of substances and descriptions of the chemical formulas (including the structural formula and the skeletal formula).
Collapsed list
Selected category:
Pharmaceutical drug
with all child subcategories
Total count of records found: 665.
Showed records: 20.
Molecular formula:
C35H46FN5O9S
CAS# 850876-88-9
Names
English:
Danoprevir [Wiki] ; ITMN-191 ; RG-7227 ;
Русский:
Данопревир ;
Molecular formula:
C20H32O5
CAS# 35121-78-9
Names
English:
(5Z)-5-{(3aR,4R,5R,6aS)-5-Hydroxy-4-[(1E,3S)-3-hydroxy-1-octen-1-yl]hexahydro-2H-cyclopenta[b]furan-2-ylidene}pentanoic acid ; (5Z)-9-Deoxy-6,9a-epoxy-D5-PGF1a ; (5Z,9a,11a,13E,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic Acid ; (9α,11α,13E,15S)-11,15-Dihydroxy-6,9-epoxyprosta-5,13-dien-1-oic acid (IUPAC) ; 6(9)-Oxy-11,15-dihydroxyprosta-5,13-dienoic Acid ; Epoprostenol ; Flolan ; PGI2 ; Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, (9α,11α,13E,15S)- (CAS) ; Prostacyclin [Wiki] ; Prostacyclin I2 ; Prostaglandin 12 ; Prostaglandin X ; U 53217 ; Vasocyclin ; Veletri ; prostaglandin I2 ;
Русский:
ПГI2 ; Простациклин [Wiki] ; простагландин I2 ;
Latina:
Epoprostenolum ;
German:
(5Z,9α,11α,13E,15S)-6,9-Epoxy-11,15-dihydroxy-prosta-5,13-dien-1-säure ; (9α,11α,13E,15S)-11,15-Dihydroxy-6,9-epoxyprosta-5,13-dien-1-säure (IUPAC) ; (Z)-5-[(3aR,4R,5R,6aS)-5-Hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]hexahydro-2H-cyclopenta[b]furan-2-yliden]pentansäure ; Prostacyclin [Wiki] ;
French:
Acide (9α,11α,13E,15S)-11,15-dihydroxy-6,9-époxyprosta-5,13-dién-1-oïque (IUPAC) ; Prostacycline [Wiki] ;
Español:
Prostaciclina [Wiki] ; Ácido 5-[7-hydroxy-8- (3-hydroxyoct-1-enyl)-4-oxabicyclo[3.3.0]oct-3-ylidene] pentanoico (IUPAC) ;
Português:
Prostaciclina [Wiki] ;
中文:
前列环素 [Wiki] ;
Italiano:
Prostacicline [Wiki] ;
Molecular formula:
C40H49BrN6O9S
CAS# 801283-95-4
Names
English:
BI-201335 ; Faldaprevir [Wiki] ; L-Prolinamide, N-[(cyclopentyloxy)carbonyl]-3-methyl-L-valyl-4-[[8-bromo-7-methoxy-2-[2-[(2-methyl-1-oxopropyl)amino]-4-thiazolyl]-4-quinolinyl]oxy]-N-[(1R,2S)-1-carboxy-2-ethenylcyclopropyl]-, (4R)- (CAS) ; N-[(Cyclopentyloxy)carbonyl]-3-methyl-L-valyl-(4R)-4-({8-bromo-2-[2-(isobutyrylamino)-1,3-thiazol-4-yl]-7-methoxy-4-quinolinyl}oxy)-N-[(1R,2S)-1-carboxy-2-vinylcyclopropyl]-L-prolinamide (IUPAC) ;
German:
N-[(Cyclopentyloxy)carbonyl]-3-methyl-L-valyl-(4R)-4-({8-brom-2-[2-(isobutyrylamino)-1,3-thiazol-4-yl]-7-methoxy-4-chinolinyl}oxy)-N-[(1R,2S)-1-carboxy-2-vinylcyclopropyl]-L-prolinamid (IUPAC) ;
French:
Faldaprévir ; N-[(Cyclopentyloxy)carbonyl]-3-méthyl-L-valyl-(4R)-4-({8-bromo-2-[2-(isobutyrylamino)-1,3-thiazol-4-yl]-7-méthoxy-4-quinoléinyl}oxy)-N-[(1R,2S)-1-carboxy-2-vinylcyclopropyl]-L-prolinamide (IUPAC) ;
Español:
Faldaprevir ;
Latina:
Faldaprevirum ;
Molecular formula:
C38H46F4N6O9S
CAS# 1365970-03-1
Names
English:
ABT-493 ; ABT493 ; Glecaprevir [Wiki] ; Mavyret ;
العربية:
غليكابريفير [Wiki] ;
Русский:
Глекапревир ;
Latina:
glecaprevirum ;
French:
glécaprévir ;
中文:
格卡瑞韦 ;
Molecular formula:
C38H50N6O9S
CAS# 1350514-68-9
Names
English:
8H-7,10-Methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxamide, N-[(1R,2S)-1-[[(cyclopropylsulfonyl)amino]carbonyl]-2-ethenylcyclopropyl]-5-(1,1-dimethylethyl)-1 ,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, (1aR,5S,8S,10R,22aR)- (CAS) ; Grazoprevir [Wiki] ; MK 5172 ; MK5172 ; Zepatier ;
Latina:
grazoprevirum ;
German:
Grazoprevir [Wiki] ;
Italiano:
Grazoprevir [Wiki] ;
Español:
Grazoprevir [Wiki] ;
العربية:
غرازوبريفير [Wiki] ;
Русский:
Гразопревир ;
Molecular formula:
C36H61N5O7S
CAS# 865466-24-6
Names
English:
(1R,2S,5S)-N-[(3S)-1-(Cyclopropylamino)-1,2-dioxo-3-heptanyl]-6,6-dimethyl-3-{3-methyl-N-[(1-{[(2-methyl-2-propanyl)sulfonyl]methyl}cyclohexyl)carbamoyl]-L-valyl}-3-azabicyclo[3.1.0]hexane-2-carboxami de (IUPAC) ; 3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[(1S)-1-[2-(cyclopropylamino)-1,2-dioxoethyl]pentyl]-3-[(2S)-2-[[[[1-[[(1,1-dimethylethyl)sulfonyl]methyl]cyclohexyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxo butyl]-6,6-dimethyl-, (1R,2S,5S)- (CAS) ; Narlaprevir [Wiki] ; SCH-900518 ; SCH900518 ;
German:
(1R,2S,5S)-N-[(3S)-1-(Cyclopropylamino)-1,2-dioxo-3-heptanyl]-6,6-dimethyl-3-{3-methyl-N-[(1-{[(2-methyl-2-propanyl)sulfonyl]methyl}cyclohexyl)carbamoyl]-L-valyl}-3-azabicyclo[3.1.0]hexan-2-carboxamid (IUPAC) ;
French:
(1R,2S,5S)-N-[(3S)-1-(Cyclopropylamino)-1,2-dioxo-3-heptanyl]-6,6-diméthyl-3-{3-méthyl-N-[(1-{[(2-méthyl-2-propanyl)sulfonyl]méthyl}cyclohexyl)carbamoyl]-L-valyl}-3-azabicyclo[3.1.0]hexane-2-carboxami de (IUPAC) ;
Русский:
(1R,2S,5S)-6,6-Диметил-3-[(2S)-2-[({1-[(2-метилпропан-2- сульфонил)метил]циклогексил}карбамоил)амиино] -3,3-диметилбутаноил]-N-[(3S)-1-(циклопропиламино) -1,2-диоксогептан-3-ил]-3-азабицикло[3.1.0]гексан-2-карбоксамид (IUPAC) ; Нарлапревир [Wiki] ;
Molecular formula:
C40H43N7O7S
CAS# 1216941-48-8
Names
English:
(2R,6S,12Z,13aS,14aR,16aS)-N-(Cyclopropylsulfonyl)-6-{[(5-methyl-2-pyrazinyl)carbonyl]amino}-5,16-dioxo-2-(6-phenanthridinyloxy)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydrocyclopropa[e]pyrrolo [1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide (IUPAC) ; ABT-450 ; Cyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide, N-(cyclopropylsulfonyl)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-6-[[(5-methyl-2-pyrazinyl)carbonyl]amino]-5,16-di oxo-2-(6-phenanthridinyloxy)-, (2R,6S,12Z,13aS,14aR,16aS)- (CAS) ; Paritaprevir [Wiki] ; Veruprevir ; Viekira Pak ;
German:
(2R,6S,12Z,13aS,14aR,16aS)-N-(Cyclopropylsulfonyl)-6-{[(5-methyl-2-pyrazinyl)carbonyl]amino}-5,16-dioxo-2-(6-phenanthridinyloxy)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydrocyclopropa[e]pyrrolo [1,2-a][1,4]diazacyclopentadecin-14a(5H)-carboxamid (IUPAC) ; Paritaprevir [Wiki] ;
French:
(2R,6S,12Z,13aS,14aR,16aS)-N-(Cyclopropylsulfonyl)-6-{[(5-méthyl-2-pyrazinyl)carbonyl]amino}-5,16-dioxo-2-(6-phénanthridinyloxy)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tétradécahydrocyclopropa[e]pyrrolo [1,2-a][1,4]diazacyclopentadécine-14a(5H)-carboxamide (IUPAC) ; Paritaprévir [Wiki] ;
Latina:
paritaprevirum ;
Русский:
Паритапревир [Wiki] ;
العربية:
باريتابريفير [Wiki] ;
日本語:
パリタプレビル [Wiki] ;
Español:
paritaprevir ;
Molecular formula:
C38H47N5O7S2
CAS# 923604-59-5
Names
English:
(2R,3aR,10Z,11aS,12aR,14aR)-N-(Cyclopropylsulfonyl)-2-{[2-(4-isopropyl-1,3-thiazol-2-yl)-7-methoxy-8-methyl-4-quinolinyl]oxy}-5-methyl-4,14-dioxo-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydrocycl openta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxamide (IUPAC) ; (2R,3aR,10Z,11aS,12aR,14aR)-N-(cyclopropylsulfonyl)-2-({7-methoxy-8-methyl-2-[4-(1-methylethyl)thiazol-2-yl]quinolin-4-yl}oxy)-5-methyl-4,14-dioxo-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydrocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxamide ; Cyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxamide, N-(cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiaz olyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxo-, (2R,3aR,10Z,11aS,12aR,14aR)- (CAS) ; Galexos ; Olysio ; Simeprevir ; Sovriad ;
German:
(2R,3aR,10Z,11aS,12aR,14aR)-N-(Cyclopropylsulfonyl)-2-{[2-(4-isopropyl-1,3-thiazol-2-yl)-7-methoxy-8-methyl-4-chinolinyl]oxy}-5-methyl-4,14-dioxo-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydrocycl openta[c]cyclopropa[g][1,6]diazacyclotetradecin-12a(1H)-carboxamid (IUPAC) ;
French:
(2R,3aR,10Z,11aS,12aR,14aR)-N-(Cyclopropylsulfonyl)-2-{[2-(4-isopropyl-1,3-thiazol-2-yl)-7-méthoxy-8-méthyl-4-quinoléinyl]oxy}-5-méthyl-4,14-dioxo-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tétradécahydrocyc lopenta[c]cyclopropa[g][1,6]diazacyclotétradécine-12a(1H)-carboxamide (IUPAC) ; Siméprévir [Wiki] ;
العربية:
سيميبريفير [Wiki] ;
Español:
Simeprevir [Wiki] ;
Italiano:
Simeprevir [Wiki] ;
Português:
Simeprevir [Wiki] ;
中文:
司美匹韋 [Wiki] ;
Русский:
Симепревир ;
Molecular formula:
C43H53N5O8S
CAS# 1001667-23-7
Names
English:
(4R)-N-{(1R,2S)-1-[(Cyclopropylsulfonyl)carbamoyl]-2-vinylcyclopropyl}-1-{(2S)-3,3-dimethyl-2-[2-oxo-2-(1-piperidinyl)ethyl]butanoyl}-4-[(7-methoxy-2-phenyl-4-quinolinyl)oxy]-L-prolinamide (IUPAC) ; 2-Pyrrolidinecarboxamide, N-[(1R,2S)-1-[[(cyclopropylsulfonyl)amino]carbonyl]-2-ethenylcyclopropyl]-1-[(2S)-3,3-dimethyl-1-oxo-2-[2-oxo-2-(1-piperidinyl)ethyl]butyl]-4-[(7-methoxy-2-phenyl-4-quinoliny l)oxy]-, (2S,4R)- (CAS) ; ACH-1625 ; Sovaprevir [Wiki] ;
Русский:
Совапревир ;
German:
(4R)-N-{(1R,2S)-1-[(Cyclopropylsulfonyl)carbamoyl]-2-vinylcyclopropyl}-1-{(2S)-3,3-dimethyl-2-[2-oxo-2-(1-piperidinyl)ethyl]butanoyl}-4-[(7-methoxy-2-phenyl-4-chinolinyl)oxy]-L-prolinamid (IUPAC) ;
French:
(4R)-N-{(1R,2S)-1-[(Cyclopropylsulfonyl)carbamoyl]-2-vinylcyclopropyl}-1-{(2S)-3,3-diméthyl-2-[2-oxo-2-(1-pipéridinyl)éthyl]butanoyl}-4-[(7-méthoxy-2-phényl-4-quinoléinyl)oxy]-L-prolinamide (IUPAC) ; Sovaprévir ;
Latina:
Sovaprevirum ;
Español:
Sovaprevir ;
Molecular formula:
C36H53N7O6
CAS# 402957-28-2
Names
English:
(1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-Cyclohexyl-2-[(2-pyrazinylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxo-3-hexanyl]octahydrocyclopenta[c]pyrrole-1-carboxamid e (non-preferred name) (IUPAC) ; 402957-28-2 ; Incivek ; Incivo ; LY-570310 ; Telaprevir [Wiki] ; Telavic ; VX-950 ;
German:
(1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-Cyclohexyl-2-[(2-pyrazinylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxo-3-hexanyl]octahydrocyclopenta[c]pyrrol-1-carboxamid (non-preferred name) (IUPAC) ; Telaprevir [Wiki] ;
French:
(1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-Cyclohexyl-2-[(2-pyrazinylcarbonyl)amino]acétyl}amino)-3,3-diméthylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxo-3-hexanyl]octahydrocyclopenta[c]pyrrole-1-carboxamid e (non-preferred name) (IUPAC) ; Télaprévir [Wiki] ;
Русский:
Телапревир ;
العربية:
تيلابريفير [Wiki] ;
Español:
Telaprevir [Wiki] ;
Italiano:
Telaprevir [Wiki] ;
日本語:
テラプレビル [Wiki] ;
Português:
Telaprevir [Wiki] ;
Molecular formula:
C38H55N5O9S
CAS# 923590-37-8
Names
English:
(1R,21S,24S)-21-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-ethylcyclopropyl]-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.14,7 .06,11 ]heptacosa-6(11),7,9-triene-24-carboxamide (IUPAC) ; MK-7009 ; Vaniprevir [Wiki] ;
Русский:
Ванипревир ;
Molecular formula:
C40H52F4N6O9S
CAS# 1535212-07-7
Names
English:
(1R,18R,20R,24S,27S,28S)-24-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-[(1-methylcyclopropyl)sulfonylcarbamoyl]cyclopropyl]-28-ethyl-13,13-difluoro-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetrazapentacyclo[24.2.1.03,12 .05,10 .018,20 ]nonacosa-3,5(10),6,8,11-pentaene-27-carboxamide (IUPAC) ; 8H-7,10-Methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxamide, N-[(1R,2R)-2-(difluoromethyl)-1-[[[(1-methylcyclopropyl)sulfonyl]amino]carbonyl]cyclopropyl]-5-(1 ,1-dimethylethyl)-9-ethyl-18,18-difluoro-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, (1aR,5S,8S,9S,10R,22aR)- (CAS) ; GS-9857 ; Voxilaprevir [Wiki] ;
Español:
voxilaprevir ;
French:
voxilaprévir ;
Latina:
voxilaprevirum ;
Русский:
Воксилапревир ;
العربية:
فوكسيلابريفير ;
中文:
伏西瑞韦 ;
Molecular formula:
C40H50N8O6
CAS# 1009119-64-5
Names
English:
BMS-790052 ; BMS790052 ; Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, dimethyl ester (CAS) ; Daclatasvir [Wiki] ; Daklinza ; Methyl [(2S)-1-{(2S)-2-[4-(4'-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1H-imidazol-4-yl}-4-biphenylyl)-1H-imidazol-2-yl]-1-pyrrolidinyl}-3-methyl-1-oxo-2-butanyl]c arbamate (IUPAC) ;
Русский:
Даклатасвир [Wiki] ;
French:
Daclatasvir [Wiki] ; [(2S)-1-{(2S)-2-[4-(4'-{2-[(2S)-1-{(2S)-2-[(Méthoxycarbonyl)amino]-3-méthylbutanoyl}-2-pyrrolidinyl]-1H-imidazol-4-yl}-4-biphénylyl)-1H-imidazol-2-yl]-1-pyrrolidinyl}-3-méthyl-1-oxo-2-butanyl]carbamat e de méthyle (IUPAC) ;
German:
Methyl-[(2S)-1-{(2S)-2-[4-(4'-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1H-imidazol-4-yl}-4-biphenylyl)-1H-imidazol-2-yl]-1-pyrrolidinyl}-3-methyl-1-oxo-2-butanyl]c arbamat (IUPAC) ;
العربية:
داكلاتازفر [Wiki] ;
Español:
Daclatasvir [Wiki] ; Daklinza ;
日本語:
ダクラタスビル [Wiki] ;
Molecular formula:
C49H55N9O7
CAS# 1370468-36-2
Names
English:
Carbamic acid, N,N'-[[(6S)-6-phenyl-6H-indolo[1,2-c][1,3]benzoxazine-3,10-diyl]bis[1H-imidazole-4,2-diyl(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, dimethyl ester (CAS) ; Elbasvir [Wiki] ; MK 8742 ; Methyl {(2S)-1-[(2S)-2-{4-[(6S)-3-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1H-imidazol-4-yl}-6-phenylindolo[1,2-c][1,3]benzoxazin-10-yl]-1H-imidazol-2-yl}-1-pyrrol idinyl]-3-methyl-1-oxo-2-butanyl}carbamate (IUPAC) ;
French:
elbasvir ; {(2S)-1-[(2S)-2-{4-[(6S)-3-{2-[(2S)-1-{(2S)-2-[(Méthoxycarbonyl)amino]-3-méthylbutanoyl}-2-pyrrolidinyl]-1H-imidazol-4-yl}-6-phénylindolo[1,2-c][1,3]benzoxazin-10-yl]-1H-imidazol-2-yl}-1-pyrrolidinyl] -3-méthyl-1-oxo-2-butanyl}carbamate de méthyle (IUPAC) ;
Latina:
elbasvirum ;
German:
Elbasvir [Wiki] ; Methyl-{(2S)-1-[(2S)-2-{4-[(6S)-3-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1H-imidazol-4-yl}-6-phenylindolo[1,2-c][1,3]benzoxazin-10-yl]-1H-imidazol-2-yl}-1-pyrrol idinyl]-3-methyl-1-oxo-2-butanyl}carbamat (IUPAC) ;
العربية:
إلباسفير [Wiki] ;
Español:
Elbasvir [Wiki] ;
Molecular formula:
C49H54F2N8O6
CAS# 1256388-51-8
Names
English:
Carbamic acid, N-[(1S)-1-[[(6S)-6-[5-[9,9-difluoro-7-[2-[(1R,3S,4S)-2-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-azabicyclo[2.2.1]hept-3-yl]-1H-benzimidazol-6-yl]-9H-fluoren-2-yl]-1H-imid azol-2-yl]-5-azaspiro[2.4]hept-5-yl]carbonyl]-2-methylpropyl]-, methyl ester (CAS) ; GS 5885 ; Ledipasvir [Wiki] ; Methyl [(2S)-1-{(1R,3S,4S)-3-[5-(9,9-difluoro-7-{2-[(6S)-5-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-5-azaspiro[2.4]hept-6-yl]-1H-imidazol-4-yl}-9H-fluoren-2-yl)-1H-benzimidazol-2-yl]-2-azabi cyclo[2.2.1]hept-2-yl}-3-methyl-1-oxo-2-butanyl]carbamate (IUPAC) ;
Русский:
Ледипасвир [Wiki] ;
French:
Lédipasvir [Wiki] ; [(2S)-1-{(1R,3S,4S)-3-[5-(9,9-Difluoro-7-{2-[(6S)-5-{(2S)-2-[(méthoxycarbonyl)amino]-3-méthylbutanoyl}-5-azaspiro[2.4]hept-6-yl]-1H-imidazol-4-yl}-9H-fluorén-2-yl)-1H-benzimidazol-2-yl]-2-azabicyclo[2 .2.1]hept-2-yl}-3-méthyl-1-oxo-2-butanyl]carbamate de méthyle (IUPAC) ;
Latina:
Ledipasvirum ;
German:
Methyl-[(2S)-1-{(1R,3S,4S)-3-[5-(9,9-difluor-7-{2-[(6S)-5-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-5-azaspiro[2.4]hept-6-yl]-1H-imidazol-4-yl}-9H-fluoren-2-yl)-1H-benzimidazol-2-yl]-2-azabic yclo[2.2.1]hept-2-yl}-3-methyl-1-oxo-2-butanyl]carbamat (IUPAC) ;
Español:
Ledipasvir [Wiki] ;
Italiano:
Ledipasvir [Wiki] ;
日本語:
レジパスビル [Wiki] ;
Português:
Ledipasvir [Wiki] ;
中文:
雷迪帕韦 [Wiki] ;
العربية:
ليديباسفير [Wiki] ;
Molecular formula:
C60H72N8O6
CAS# 1415119-52-6
Names
English:
ACH-3102 ; Carbamic acid, N,N'-[tricyclo[8.2.2.24,7 ]hexadeca-4,6,10,12,13,15-hexaene-5,11-diylbis[1H-benzimidazole-5,2-diyl[(2S,3aS,7aS)-octahydro-1H-indole-2,1-diyl][(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediy l]]]bis-, dimethyl ester (CAS) ; Methyl {(2S)-1-[(2S,3aS,7aS)-2-{5-[11-{2-[(2S,3aS,7aS)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}octahydro-1H-indol-2-yl]-1H-benzimidazol-5-yl}tricyclo[8.2.2.24,7 ]hexadeca-1(12),4,6,10,13, 15-hexaen-5-yl]-1H-benzimidazol-2-yl}octahydro-1H-indol-1-yl]-3-methyl-1-oxo-2-butanyl}carbamate (IUPAC) ; Odalasvir [Wiki] ;
French:
odalasvir ; {(2S)-1-[(2S,3aS,7aS)-2-{5-[11-{2-[(2S,3aS,7aS)-1-{(2S)-2-[(Méthoxycarbonyl)amino]-3-méthylbutanoyl}octahydro-1H-indol-2-yl]-1H-benzimidazol-5-yl}tricyclo[8.2.2.24,7 ]hexadéca-1(12),4,6,10,13,15-hexaén-5-yl]-1H-benzimidazol-2-yl}octahydro-1H-indol-1-yl]-3-méthyl-1-oxo-2-butanyl}carbamate de méthyle (IUPAC) ;
Español:
odalasvir ;
Latina:
odalasvirum ;
Русский:
одаласвир ;
العربية:
أودالاسفير ;
中文:
奥达拉韦 ;
Molecular formula:
C50H67N7O8
CAS# 1258226-87-7
Names
English:
ABT-267 ; Dimethyl ({(2S,5S)-1-[4-(2-methyl-2-propanyl)phenyl]-2,5-pyrrolidinediyl}bis{4,1-phenylenecarbamoyl(2S)-2,1-pyrrolidinediyl[(2S)-3-methyl-1-oxo-1,2-butanediyl]})biscarbamate (IUPAC) ; Ombitasvir [Wiki] ;
Русский:
Омбитасвир [Wiki] ;
العربية:
أمبيتاسفير [Wiki] ;
German:
Dimethyl-({(2S,5S)-1-[4-(2-methyl-2-propanyl)phenyl]-2,5-pyrrolidindiyl}bis{4,1-phenylencarbamoyl(2S)-2,1-pyrrolidindiyl[(2S)-3-methyl-1-oxo-1,2-butandiyl]})biscarbamat (IUPAC) ; Ombitasvir [Wiki] ;
日本語:
オムビタスビル [Wiki] ;
French:
({(2S,5S)-1-[4-(2-Méthyl-2-propanyl)phényl]-2,5-pyrrolidinediyl}bis{4,1-phénylènecarbamoyl(2S)-2,1-pyrrolidinediyl[(2S)-3-méthyl-1-oxo-1,2-butanediyl]})biscarbamate de diméthyle (IUPAC) ; Ombitasvir ;
Latina:
Ombitasvirum ;
Español:
Ombitasvir ;
Molecular formula:
C42H50N8O6
CAS# 1242087-93-9
Names
English:
Carbamic acid, N-[(1S)-1-[[(2S)-2-[5-[6-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-benzimidazol-6-yl]-2-naphthalenyl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl ]-2-methylpropyl]-, methyl ester (CAS) ; Methyl [(2S)-1-{(2S)-2-[4-(6-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1H-benzimidazol-5-yl}-2-naphthyl)-1H-imidazol-2-yl]-1-pyrrolidinyl}-3-methyl-1-oxo-2-butanyl] carbamate (IUPAC) ; PPI-668 ; Ravidasvir [Wiki] ;
French:
[(2S)-1-{(2S)-2-[4-(6-{2-[(2S)-1-{(2S)-2-[(Méthoxycarbonyl)amino]-3-méthylbutanoyl}-2-pyrrolidinyl]-1H-benzimidazol-5-yl}-2-naphtyl)-1H-imidazol-2-yl]-1-pyrrolidinyl}-3-méthyl-1-oxo-2-butanyl]carbamat e de méthyle (IUPAC) ;
German:
Methyl-[(2S)-1-{(2S)-2-[4-(6-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1H-benzimidazol-5-yl}-2-naphthyl)-1H-imidazol-2-yl]-1-pyrrolidinyl}-3-methyl-1-oxo-2-butanyl] carbamat (IUPAC) ;
Molecular formula:
C47H48N8O6S2
CAS# 1312547-19-5
Names
English:
Carbamic acid, N-[(1R)-2-[(2S)-2-[4-[4-[6-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-benzimidazol-5-yl]thieno[3,2-b]thien-3-yl]phenyl]-1H-imidazol-2-yl]-1-pyrr olidinyl]-2-oxo-1-phenylethyl]-, methyl ester (CAS) ; IDX-719 ; Methyl {(1R)-2-[(2S)-2-{4-[4-(6-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1H-benzimidazol-5-yl}thieno[3,2-b]thiophen-3-yl)phenyl]-1H-imidazol-2-yl}-1-pyrrolidinyl]- 2-oxo-1-phenylethyl}carbamate (IUPAC) ; Samatasvir [Wiki] ;
French:
samatasvir ; {(1R)-2-[(2S)-2-{4-[4-(6-{2-[(2S)-1-{(2S)-2-[(Méthoxycarbonyl)amino]-3-méthylbutanoyl}-2-pyrrolidinyl]-1H-benzimidazol-5-yl}thiéno[3,2-b]thiophén-3-yl)phényl]-1H-imidazol-2-yl}-1-pyrrolidinyl]-2-oxo-1 -phényléthyl}carbamate de méthyle (IUPAC) ;
German:
Methyl-{(1R)-2-[(2S)-2-{4-[4-(6-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1H-benzimidazol-5-yl}thieno[3,2-b]thiophen-3-yl)phenyl]-1H-imidazol-2-yl}-1-pyrrolidinyl]- 2-oxo-1-phenylethyl}carbamat (IUPAC) ; Samatasvir [Wiki] ;
Latina:
samatasvirum ;
Español:
samatasvir ;
Русский:
Саматасвир ;
Molecular formula:
C49H54N8O8
CAS# 1377049-84-7
Names
English:
Carbamic acid, N-[(1R)-2-[(2S,4S)-2-[4-[1,11-dihydro-2-[(2S,5S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-5-methyl-2-pyrrolidinyl][2]benzopyrano[4',3':6,7]naphth[1,2-d]imidazol-9-yl]-1H- imidazol-2-yl]-4-(methoxymethyl)-1-pyrrolidinyl]-2-oxo-1-phenylethyl]-, methyl ester (CAS) ; GS-5816 ; GS5816 ; KCU0C7RS7Z ; Methyl {(2S)-1-[(2S,5S)-2-(9-{2-[(2S,4S)-1-{(2R)-2-[(methoxycarbonyl)amino]-2-phenylacetyl}-4-(methoxymethyl)-2-pyrrolidinyl]-1H-imidazol-4-yl}-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol -2-yl)-5-methyl-1-pyrrolidinyl]-3-methyl-1-oxo-2-butanyl}carbamate (IUPAC) ; Velpatasvir [Wiki] ;
Русский:
Велпатасвир [Wiki] ;
العربية:
فلباتاسفير [Wiki] ;
Español:
Velpatasvir [Wiki] ;
French:
Velpatasvir [Wiki] ; {(2S)-1-[(2S,5S)-2-(9-{2-[(2S,4S)-1-{(2R)-2-[(Méthoxycarbonyl)amino]-2-phénylacétyl}-4-(méthoxyméthyl)-2-pyrrolidinyl]-1H-imidazol-4-yl}-1,11-dihydroisochroméno[4',3':6,7]naphto[1,2-d]imidazol-2-yl)-5 -méthyl-1-pyrrolidinyl]-3-méthyl-1-oxo-2-butanyl}carbamate de méthyle (IUPAC) ;
German:
Methyl-{(2S)-1-[(2S,5S)-2-(9-{2-[(2S,4S)-1-{(2R)-2-[(methoxycarbonyl)amino]-2-phenylacetyl}-4-(methoxymethyl)-2-pyrrolidinyl]-1H-imidazol-4-yl}-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol -2-yl)-5-methyl-1-pyrrolidinyl]-3-methyl-1-oxo-2-butanyl}carbamat (IUPAC) ;
中文:
维帕他韦 ;